Irish drugs agency backs public funding for Wegovy, warns of substantial cost

Ireland's drugs spending agency has recommended public funding for the weight-loss drug Wegovy, potentially benefiting up to one million people. The agency warns of 'substantial' cost implications, signaling a major fiscal commitment. This marks a notable policy shift toward obesity treatment as a public health priority, but the final decision and funding mechanism remain uncertain.